Clinical Trial Update: Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of AS1404 with docetaxel in hormone-refractory metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AS1404
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Antisoma Research | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED